Siyata Mobile Announces Additional U.S. Tier 1 Operator for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
229
Siyata Mobile Announces Additional U.S. Tier 1 Operator for Uniden® UV350 4G/LTE In-Vehicle Device

Carrier Launch Streamlined and is Expected to be Completed in Q4 2018

MONTREAL, July 16, 2018 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. (the "Company" or "Siyata") (TSX-V: SIM ) (OTCQX:SYATF) is pleased to announce that an additional Tier 1 Cellular Operator in the United States has commenced network certification for the Uniden® UV350, the world’s first and only all-in-one 4G/LTE dedicated in-vehicle cellular device.

The approval process is being streamlined and is expected to be completed in Q4 of 2018 as the Uniden® UV350 has received all major government and industry approvals, including Federal Communications Commission (FCC) Android compatibility test suite (CTS), and PCS Type Certification Review Board (PTCRB). 

Marc Seelenfreund, President and CEO of Siyata, stated, “We are very excited to be launching the UV350 in the coming months with multiple leading cellular network providers in North America. As a first-to-market, in-vehicle cellular IoT device, the wide distribution between these carriers corners a market 30 times the size of our existing sales channels providing the potential for high impact revenue growth in the foreseeable future. Very few cellular devices can achieve the levels of certification and approvals we have received, and it serves as a strong platform to begin working with additional operators in the future.”

The Uniden® UV350 is an all-in-one, purpose built in-vehicle Internet of Things (“IoT”) device to upgrade antiquated two-way radio technology as a smarter, more advanced solution to communicate, navigate and create in-vehicle efficiencies never seen before in the commercial fleet and vehicle market. Android-based applications and other features available for download on the Uniden® UV350 help improve driver/worker safety and create efficiencies not offered by single purpose hardware which clutter the inside of a vehicle cabin which can be distracting for drivers.

As cellular operators, generally do not generate revenue from two-way radio, there is a strong push to gain market share from two-radio network providers, with an estimated 12.6 million commercial vehicles currently registered in the United States alone. To do this, cellular operators can replace their customer’s two-way radios and other single purpose hardware systems with cellular-based solutions compatible on their cellular network with a SIM card.

This upgrade allows carriers to increase ARPU from existing enterprise accounts, sell additional software services, bundle voice, data and software packages while creating a safer driving experience.

The Uniden® UVE350 allows driver to keep their eyes on the road and hands on the wheel.

Government and Industry Approvals

The government and industry approvals stated below are the highest global certifications for cellular devices and will allow the company to sell the UV350 in multiples markets both at cellular operators and other distribution channels and serves as a solid platform for its North American growth strategy.

An FCC approval grants the company a license to sell the UV350 in the United States. For the UV350 to have been approved, the company submitted documentation, had the device tested in an independent lab and has physically labelled the device with its FCC unique identifier, making it ready for sale in the United States.

The CTS suite is a compatibility test, run by Android, and provides tools for manufacturers to ensure applications run on a variety of devices. The CTS runs on a desktop machine, testing the UV350 to ensure software compatibility is consistent throughout the development process. The test cases are a set of unit tests designed to mimic the functionality of the UV350, with the intent of revealing any issues with incompatibility. The company is pleased to have passed CTS certification, ensuring Android operating systems will run consistently on the UV350.

PTCRB defines the test requirements to verify compliance with global industry standards for wireless cellular devices. PTCRB is an important classification for wireless devices, and the certification adds confidence that the UV350 can successfully transfer information with mobile networks. Without PTCRB certification, manufacturers run the risk that their devices will be blocked on wireless networks. The Siyata Mobile technical team has successfully achieved PTCRB status with its previous generation models (UCP100 and UCP200), and the company is pleased to add the UV350 to that list.

These approvals are the highest global certifications for cellular devices and will allow the company to sell the UV350 in multiples markets both at cellular operators and other distribution channels and serves as a solid platform for its North American growth strategy.

The Company continues to work with the U.S. Tier 1 operator and Canadian Tier 1 operator announced in July 2017 , and August 2017 , and it will announce further updates on the progress in the coming weeks.

About Siyata A TSX Venture Top 50 Company, Siyata Mobile Inc. is a leading global developer and provider of cellular communications systems for enterprise customers, specializing in connected vehicle products for professional fleets, marketed under the Uniden® Cellular brand. Since developing the world’s first 3G connected vehicle device, Siyata has been a pioneer in the industry, launching the world’s first 4G LTE all-in-one fleet communications device in 2017. Incorporating voice, push-to-talk over cellular, data, and fleet management solutions into a single device, the company aims to become the connected vehicle communications device of choice for commercial vehicles and fleets around the world. Siyata also offers rugged phones for industrial users and signal boosters for homes, buildings, and fleets with poor cell coverage. Siyata’s customers include cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia, and the Middle East.

Visit www.siyatamobile.com and http://www.unidencellular.com/ to learn more.

On Behalf of the Board of Directors of:

SIYATA MOBILE INC.

Marc Seelenfreund CEO and Chairman

Investor Relations: Arlen Hansen Kin Communications 1-866-684-6730 SIM@kincommunications.com

Sales Department: Glenn Kennedy, VP Sales Siyata Mobile Inc. 416-892-1823 glenn_kennedy@siyatamobile.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...2457872094

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Flora Growth Corp Sees 6% Surge in After-Hours Performance

Updated Category News Views 87

A Surge in After-Hours Trading for Flora Growth Corp Flora Growth Corp. (NASDAQ: FLGC) recently demonstrated significant volatility by surging 5.98% to $10.55 during after-hours trading. This movement came not long after closing at $9.96, which marked an increase of 3.59% earlier that day. Insights from Recent SEC Filing Regulation A Filing In a notable move, Flora Growth...

Continue Reading
Qubs Introduces Qubitunes, A New Interactive Audio Experience

Updated Category News Views 205

Qubs Launches Qubitunes for Creative Play Qubs has unveiled an exciting new product, Qubitunes, which has already won the 'Top Toy' award in the startup category at a prestigious Toy Fair. This innovative toy is set to transform playtime for children by offering a unique platform where they can express their creativity and dive into their own audio storytelling...

Continue Reading
Asyad Group's Expert Transport of Heavy Cryogenic Tank

Updated Category News Views 126

Asyad Group's Successful Transport of Cryogenic Tank Asyad Group has recently completed a remarkable international transport operation, successfully moving a 115 metric ton pressurized cryogenic tank from Northern India to a major destination in Saudi Arabia. This endeavor highlights the Group's expertise in cross-border logistics. A Journey of Precision The transport...

Continue Reading
Famous Toastery Launches Holiday Fundraising Efforts

Updated Category News Views 134

Famous Toastery's Compassionate Campaign for Local Communities The Famous Toastery, known for its delightful breakfast and brunch offerings, is stepping up this holiday season with a noble initiative aimed at fighting hunger. This renowned franchise is collaborating with Feeding the Carolinas, encouraging guests to make donations that will significantly impact individuals...

Continue Reading
Jiayin Group's Upcoming Earnings Call Set for November 25, 2025

Updated Category News Views 190

Jiayin Group Inc. Announces Q3 2025 Financial Results Release Jiayin Group Inc. (NASDAQ: JFIN), a prominent fintech platform in China, has shared significant news that it will unveil its unaudited financial outcomes for the third quarter of 2025. This crucial announcement is set to occur before the U.S. markets open on November 25, 2025. The anticipation surrounding these...

Continue Reading